Log In
Print
BCIQ
Print
Print this Print this
 

AHRO-001

Also known as: Hyodeoxycholic acid (HDCA)

  Manage Alerts
Collapse Summary General Information
Company AtheroNova Inc.
DescriptionBile salt hyodeoxycholic acid
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAtherosclerosis
Indication DetailsTreat and prevent atherosclerotic plaque; Treat atherosclerosis
Regulatory Designation

Partner

Maxwell Biotech Group Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today